The relationship of gamma-glutamyltransferase to C-reactive protein and arterial stiffness

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 3, 2008, Pages 211-219

  Saijo, Yasuaki ^a   Utsugi, Megumi ^b   Yoshioka, Eiji ^b   Horikawa, Naoko ^b   Sato, Tetsuro ^b   Gong, Yingyan ^b   Kishi, Reiko ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterial stiffness; C reactive protein; Gamma glutamyltransferase; Pulse wave velocity

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ANKLE; ARTICLE; ATHEROSCLEROSIS; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS; BRACHIAL ARTERY; FEMALE; HEART RATE; HUMAN; JAPAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; QUESTIONNAIRE; RISK FACTOR; VASCULARIZATION;

ANKLE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BODY MASS INDEX; BRACHIAL ARTERY; C-REACTIVE PROTEIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEART RATE; HUMANS; JAPAN; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 40649127728     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.10.002     Document Type: Article

References (50)

1. Teschke R., Brand A., and Strohmeyer G. Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun 75 (1977) 718-724
2. Arndt V., Brenner H., Rothenbacher D., Zschenderlein B., Fraisse E., and Fliedner T.M. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 71 (1998) 405-412
3. Karlson B.W., Wiklund O., Hallgren P., Sjolin M., Lindqvist J., and Herlitz J. Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 247 (2000) 449-456
4. Betro M.G., Oon R.C., and Edwards J.B. Gamma-glutamyl transpeptidase and other liver function tests in myocardial infarction and heart failure. Am J Clin Pathol 60 (1973) 679-683
5. Wannamethee G., Ebrahim S., and Shaper A.G. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 142 (1995) 699-708
6. Jousilahti P., Rastenyte D., and Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 31 (2000) 1851-1855
7. Bots M.L., Salonen J.T., Elwood P.C., Nikitin Y., Freire de Concalves A., Inzitari D., et al. Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project. J Epidemiol Community Health Suppl. 1 (2002) i25-i29
8. Daeppen J.B., Smith T.L., and Schuckit M.A. Influence of age and body mass index on gamma-glutamyltransferase activity: a 15-year follow-up evaluation in a community sample. Alcohol Clin Exp Res 22 (1998) 941-944
9. Lee D.H., Silventoinen K., Jacobs Jr. D.R., Jousilahti P., and Tuomileto J. gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab 89 (2004) 5410-5414
10. van Barneveld T., Seidell J.C., Traag N., and Hautvast J.G. Fat distribution and gamma-glutamyl transferase in relation to serum lipids and blood pressure in 38-year old Dutch males. Eur J Clin Nutr 43 (1989) 809-818
11. Nilssen O., Forde O.H., and Brenn T. The Tromso Study. Distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 132 (1990) 318-326
12. Yamada Y., Ikai E., Tsuritani I., Ishizaki M., Honda R., and Ishida M. The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: common in drinkers and non-drinkers. Hypertens Res 18 (1995) 295-301
13. Lee D.H., Jacobs Jr. D.R., Gross M., Kiefe C.I., Roseman J., Lewis C.E., et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49 (2003) 1358-1366
14. Nakanishi N., Takatorige T., and Suzuki K. Daily life activity and risk of developing impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. Diabetologia 47 (2004) 1768-1775
15. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
16. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
17. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
18. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
19. Saijo Y., Kiyota N., Kawasaki Y., Miyazaki Y., Kashimura J., Fukuda M., et al. Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 6 (2004) 249-258
20. Yamada S., Gotoh T., Nakashima Y., Kayaba K., Ishikawa S., Nago N., et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 153 (2001) 1183-1190
21. Laaksonen D.E., Niskanen L., Nyyssonen K., Punnonen K., Tuomainen T.P., Valkonen V.P., et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 (2004) 1403-1410
22. Hoekstra T., Geleijnse J.M., Schouten E.G., Kok F.J., and Kluft C. Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly. Nutr Metab Cardiovasc Dis 15 (2005) 270-278
23. Lee D.H., and Jacobs Jr. D.R. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 178 (2005) 327-330
24. Bo S., Gambino R., Durazzo M., Guidi S., Tiozzo E., Ghione F., et al. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol 11 (2005) 7109-7117
25. Yamada J., Tomiyama H., Yambe M., Koji Y., Motobe K., Shiina K., et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis 189 (2006) 198-205
26. Lehmann E.D. Clinical value of aortic pulse-wave velocity measurement. Lancet 354 (1999) 528-529
27. Asmar R., Benetos A., Topouchian J., Laurent P., Pannier B., Brisac A.M., et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 26 (1995) 485-490
28. Laurent S., Katsahian S., Fassot C., Tropeano A.I., Gautier I., Laloux B., et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34 (2003) 1203-1206
29. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
30. Guerin A.P., Blacher J., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (2001) 987-992
31. Mule G., Cottone S., Mongiovi R., Cusimano P., Mezzatesta G., Seddio G., et al. Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 16 (2006) 54-59
32. Japan Society of Clinical Chemistry. Recommendation for measuring enzyme activity in human serum (in Japanese with English abstract). Jpn J Clin Chem 18 (1989) 21162
33. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of non-invasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
34. Tomiyama H., Yamashina A., Arai T., Hirose K., Koji Y., Chikamori T., et al. Influences of age and gender on results of non-invasive brachial-ankle pulse wave velocity measurement-a survey of 12,517 subjects. Atherosclerosis 166 (2003) 303-309
35. Saijo Y., Utsugi M., Yoshioka E., Horikawa N., Sato T., Gong Y.Y., et al. Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hyperten Res 28 (2005) 283-292
36. Lee D.H., Blomhoff R., and Jacobs Jr. D.R. Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res 38 (2004) 535-539
37. Pompella A., Emdin M., Passino C., and Paolicchi A. The significance of serum gamma-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 42 (2004) 1085-1091
38. Kugelman A., Choy H.A., Liu R., Shi M.M., Gozal E., and Forman H.J. gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am J Respir Cell Mol Biol 11 (1994) 586-592
39. Takahashi Y., Oakes S.M., Williams M.C., Takahashi S., Miura T., and Joyce-Brady M. Nitrogen dioxide exposure activates gamma-glutamyl transferase gene expression in rat lung. Toxicol Appl Pharmacol 143 (1997) 388-396
40. Karp D.R., Shimooku K., and Lipsky P.E. Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 276 (2001) 3798-3804
41. 2 production, cell surface protein thiol oxidation and NF-kappa B activation status. J Cell Sci 113 (2000) 2671-2678
42. Paolicchi A., Dominici S., Pieri L., Maellaro E., and Pompella A. Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 64 (2002) 1027-1035
43. 2 production. Biochim Biophys Acta 1621 (2003) 76-83
44. Lee D.H., Gross M.D., and Jacobs Jr. D.R. Cardiovascular Risk Development in Young Adults Study. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem 50 (2004) 582-588
45. Lee D.H., Steffen L.M., and Jacobs Jr. D.R. Association between serum gamma-glutamyltransferase and dietary factors: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 79 (2004) 600-605
46. Kobayashi S., Inoue N., Ohashi Y., Terashima M., Matsui K., Mori T., et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 23 (2003) 1398-1404
47. Stranges S., Dorn J.M., Muti P., Freudenheim J.L., Farinaro E., Russell M., et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology 39 (2004) 754-763
48. Ishizaka N., Ishizaka Y., Takahashi E., Tooda E., Hashimoto H., Nagai R., et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359 (2002) 133-135
49. Ishizaka N., Ishizaka Y., Takahashi E., Toda Ei E., Hashimoto H., Ohno M., et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 105 (2002) 1028-1030
50. Vassalle C., Masini S., Bianchi F., and Zucchelli G.C. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 90 (2004) 565-566